NDC 70710-2007-03 - Deflazacort Oral Suspension
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-2007
- Requested NDC
- 70710-2007-03
- Package NDCs from labels
- 70710-2007-3, 70710-2007-03
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Doppel Farmaceutici S.r.l.
- Effective date
- 2026-11-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Deflazacort Oral Suspension | Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Doppel Farmaceutici S.r.l. | 2026-11-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-2007-3 | Deflazacort Oral Suspension | 13 mL in 1 BOTTLE | SUSPENSION | 13 | 2 | |
| 70710-2007-3 | Deflazacort Oral Suspension | 1 in 1 CARTON | SUSPENSION | 1 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-2007-3 | ML - Milliliter | 70710-2007 | 40ccc302-cbc6-450e-8d85-a62dcaa86388 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Deflazacort Oral Suspension | DEFLAZACORT | Zydus Pharmaceuticals (USA) Inc. | 14569f71-573e-49fd-b80e-b3b52531b1c8 | 2026-11-05 | Warnings, Adverse reactions | ANDA220042 70710-2007-3 70710-2007 70710200703 1870964 530bac01-4487-43bb-a9b4-62ada9166a49 14569f71-573e-49fd-b80e-b3b52531b1c8 KR5YZ6AE4B |
| JAYTHARI Oral Suspension | DEFLAZACORT | Zydus Pharmaceuticals (USA) Inc. | abf1dba1-cfd8-4a05-aa2b-ffacfbeb9fa9 | 2026-11-05 | Warnings, Adverse reactions | ANDA220042 1870964 KR5YZ6AE4B |
| FUNGAL NAIL TREATMENT | GLACIAL ACETIC ACID | Guchutang Biotechnology (Longyan) Co., Ltd | 5efd832a-e362-c8dd-e063-6294a90a107c | 2026-10-29 | Warnings | Q40Q9N063P |
| BACTERIOSTATIC | WATER | Elementco, S.A.P.I. de C.V. | 5e7465d8-dbe4-2f86-e063-6394a90a8dfb | 2026-10-23 | Warnings | LKG8494WBH |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-10-16 | Warnings | 6OZP39ZG8H |
| TheraTears Extra | CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | MEDTECH PRODUCTS INC | 77f504c1-b8e0-4371-ac3e-9d453d84714b | 2026-10-15 | Warnings | K679OBS311 |
| TheraTears Extra | CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED | MEDTECH PRODUCTS INC | f1845041-9d8d-42a0-a2cb-68def7a5aac7 | 2026-10-15 | Warnings | K679OBS311 |
| TheraTears Lubricant | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 797b0394-2f0f-4733-8d20-ec5bdf3e085d | 2026-10-15 | Warnings | K679OBS311 |
| EMFLAZA | DEFLAZACORT | PTC Therapeutics, Inc. | 31b347d2-f156-4055-9d8f-7cf0df420296 | 2026-10-13 | Warnings, Adverse reactions | 1870964 KR5YZ6AE4B |
| VitaPhyte Lubricant Eye Drops | LUBRICANT EYE DROPS | Guangzhou Liyan Cosmetics Technology Co., Ltd. | 5d39f7b1-c0ed-33dc-e063-6394a90aee31 | 2026-10-07 | Warnings | K679OBS311 |
| Deflazacort | DEFLAZACORT | Hikma Pharmaceuticals USA Inc. | 00df3169-b8e3-4584-823b-91b71807d1a6 | 2026-10-07 | Warnings, Adverse reactions | KR5YZ6AE4B |
| VitaPhyte Lubricating Eye Drops | LUBRICATING EYE DROPS | Guangzhou Liyan Cosmetics Technology Co., Ltd. | 5c6360a4-6fd9-f5f6-e063-6294a90a8e61 | 2026-09-26 | Warnings | K679OBS311 |
| TheraTears | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 17a01236-130f-495b-9f8d-92b6a23b2dc5 | 2026-09-09 | Warnings | K679OBS311 |
| Deflazacort Oral Suspension | DEFLAZACORT ORAL | Biocon Pharma Inc. | e76f35a5-711c-c511-9fd8-b8c4c0b43b85 | 2026-08-31 | Warnings, Adverse reactions | 1870964 KR5YZ6AE4B |
| REFRESH LIQUIGEL | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 4b8b2f6a-4b89-446c-9e5b-9b83c453a01d | 2026-08-28 | Warnings | K679OBS311 |
| Deflazacort | DEFLAZACORT | Doppel Farmaceutici S.r.l. | 34a03eb7-74f5-4471-e063-6394a90aca63 | 2026-08-27 | Warnings, Adverse reactions | KR5YZ6AE4B |
| JAYTHARI | DEFLAZACORT | Doppel Farmaceutici S.r.l. | 3542a1e3-acfd-6b9a-e063-6394a90a9466 | 2026-08-27 | Warnings, Adverse reactions | KR5YZ6AE4B |
| 0.9% Benzyl Alcohol Solution (Laboratory Use Only) | 0.9% BENZYL ALCOHOL SOLUTION (LABORATORY USE ONLY) | Guangzhou Huanmei Cosmetics Co., Ltd | 5976bde6-0999-ffc4-e063-6394a90aadcf | 2026-08-20 | Warnings | LKG8494WBH |
| Deflazacort Oral Suspension | DEFLAZACORT ORAL | Sun Pharmaceutical Industries, Inc. | 2fac1332-0247-1047-e063-6294a90a557f | 2026-08-13 | Warnings, Adverse reactions | 1870964 KR5YZ6AE4B |
| Lipo-Chord | ACETICUM AC, ACETYLSAL AC, ADRENOCORTICOTROPHIN, ALUMINA, ARSENICUM ALB, BORAGO, CEANOTHUS, CHELIDONIUM MAJ, CHIONANTHUS, CHLORAMPHENICOLUM, CHLORPROMAZINUM, CHOLESTERINUM, CORTISONE ACETICUM, DAMIANA, FOLLICULINUM, FUMARICUM AC, KALI IOD, LYCOPODIUM, NAT SULPHURICUM, NUX VOM, OLEUM MORRHUAE, PETROLEUM, PHENACETINUM, PHOSPHORICUM AC, PHOSPHORUS, PLUMB MET, SACCHARUM OFF, SILICEA, TARAXACUM, THYROIDINUM. | Energetix Corporation | 5c83cbd5-46fb-48a0-a739-ff9c81e7129c | 2026-08-11 | Warnings | Q40Q9N063P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.